Red Cedar Capital’s Pfizer PFE Stock Holding History

Red Cedar Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$60K	Hold	1,180	–	–	0.04%	87
2022 Q3	$52K	Buy	1,180 +94	+9%	+$4.57K	0.04%	90
2022 Q2	$57K	Buy	1,086 +586	+117%	+$29.9K	0.04%	88
2022 Q1	$26K	Hold	500	–	–	0.02%	106
2021 Q4	$29K	Hold	500	–	–	0.02%	104
2021 Q3	$22K	Hold	500	–	–	0.01%	102
2021 Q2	$20K	Hold	500	–	–	0.01%	108
2021 Q1	$18K	Hold	500	–	–	0.01%	108
2020 Q4	$18K	Sell	500 -27	-5%	-$990	0.01%	103
2020 Q3	$18K	Hold	527	–	–	0.02%	102
2020 Q2	$16K	Hold	527	–	–	0.01%	104
2020 Q1	$16K	Hold	527	–	–	0.02%	101
2019 Q4	$20K	Hold	527	–	–	0.02%	105
2019 Q3	$18K	Hold	527	–	–	0.01%	109
2019 Q2	$22K	Hold	527	–	–	0.02%	110
2019 Q1	$21K	Hold	527	–	–	0.02%	110
2018 Q4	$22K	Sell	527 -211	-29%	-$8.76K	0.02%	105
2018 Q3	$31K	Hold	738	–	–	0.03%	103
2018 Q2	$25K	Hold	738	–	–	0.02%	106
2018 Q1	$25K	Sell	738 -632	-46%	-$21.7K	0.02%	109
2017 Q4	$47K	Buy	+1,370	New	+$46.7K	0.04%	90

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Red Cedar Capital's PFE Position: Q4 2022 in Review

Red Cedar Capital held its Pfizer (PFE) position steady in Q4 2022 at 1,180 shares worth $60K. The position accounts for 0.04% of the portfolio, ranked #87.

Red Cedar Capital first reported a position in PFE in Q4 2017 and has held it in 21 quarters since. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Red Cedar Capital held 1,180 shares of Pfizer worth $60K as of Q4 2022.
Red Cedar Capital left its Pfizer share count unchanged in Q4 2022.
Pfizer made up 0.04% of Red Cedar Capital's portfolio in Q4 2022, its #87 holding.
Red Cedar Capital first reported a position in Pfizer in Q4 2017 and has held it in 21 quarters since.
3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.